• The treatment of hypertension (arterial hypertension and renovascular hypertension) and its use alone or in association with thiazides diuretics. • And the treatment of incipient nephropathy in diabetics characterised by microalbuminuria (30-300 mg/ 24h), this indication was not approved in all the EU member states.